McLardy McShane joins ‘Sam’s 1000’ to change the face of cancer care

McLardy McShane is excited to announce our getting involved with ‘Sam’s 1000’ – an initiative created by Samuel Johnson’s ‘Love Your Sister’ charity.

sam close up img
Samuel Johnson - Founder of 'Love Your Sister'

If you’re unfamiliar with ‘Love Your Sister’ or ‘Sam’s 1000’, allow us to provide some context:

‘Love Your Sister’ is a fervent Australian charity in the battle against cancer. Founded by advocate Samuel Johnson, its aim is to end cancer by driving innovations in treatment, specifically focusing on Precision Medicine.

Precision Medicine is a medical model that proposes the customisation of healthcare, with medical decisions, treatments, practices, or products being tailored to the individual patient. In the context of cancer, this involves doctors analysing a patient’s unique genetic makeup to identify the most effective treatments. This personalised approach reduces the guesswork in treatment plans and improves chances of success.

Yet, despite its immense potential, Precision Medicine is not yet standard care for all Australians. This is where ‘Sam’s 1000’ comes into play – with its mission to make Precision Medicine accessible to all cancer patients, regardless of their location, age, income, or status.

McLardy McShane is proud to join ‘Sam’s 1000’. We will be contributing $1000 per month towards this initiative, in a bid to assist ‘Love Your Sister’ in achieving their noble goal. With this commitment, we join a vast network of Australian businesses who believe in this cause and are willing to invest in the future of healthcare.

We are proud to be a part of the ‘Sam’s 1000’ initiative and stand alongside ‘Love Your Sister’ in their quest to revolutionise cancer care. We extend an open invitation to all who wish to join us on this inspiring journey.

If you’d like to learn more about ‘Love Your Sister’, click here.

You might also enjoy:

Need some insurance or financial services guidance?

Request a free consultation or quotation.